10,11-BIS-(BENZYLOXY)-21-OXADECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE
Compound with spectra: 1 NMR
![10,11-BIS-(BENZYLOXY)-21-OXADECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE](/api/compound/Av21hYeBAA2.png?ph=true&h=300&w=458 "10,11-BIS-(BENZYLOXY)-21-OXADECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE")
| SpectraBase Compound ID | Av21hYeBAA2 |
|---|---|
| InChI | InChI=1S/C34H34O3/c1-3-7-17(8-4-1)15-35-31-19-11-23-29-25-13-21(27(19)29)32(31,36-16-18-9-5-2-6-10-18)22-14-26-30-24(12-20(31)28(22)30)33(23)34(25,26)37-33/h1-10,19-30H,11-16H2 |
| InChIKey | AIJLWAIFIMPWJI-UHFFFAOYSA-N |
| Mol Weight | 490.6 g/mol |
| Molecular Formula | C34H34O3 |
| Exact Mass | 490.250795 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
5-OXANONACYCLO-[9.8.1.1(1,17).0(3,18).0(4,6).0(4,).0(6,17).0(8,12).0(15,19)]-HENICOSANE-14,20-DIONE
ENT-1-ALPHA,16-ALPHA-DIYHDROXY-KAUR-11-EN-18-OIC_ACID
Moxifloxacin
Ethyl 3-(4-nitrophenylsulfonylamino)-4,6-diphenylthieno[2,3-b]pyridine-2-carboxylate
3'-(3-methylphenyl)-2,3-dihydrospiro[indene-1,2'-[1,3]thiazolidine]-2,4'-dione
O-METHYL-DIHYDRO-BOTRYDIAL
GERMACRA-4Z,11(13)-DIEN-12,6-A-OLIDE,2-B-ACETOXY-3-B,10-B-EPOXY-3-A-HYDROXY-8-B-TIGLOYLOXY
11-ACETOXY-24-METHYLENE-1-BETA,3-BETA,6-ALPHA-TRIHYDROXY-9,11-SECO-CHOLEST-7-EN-9-ONE
2-(2'-ETHYLPROP-2'-ENYL)-1-HYDROXY-4-METHOXY-3-(2''-METHYLBUT-1''-ENYL)-ANTHRAQUINONE
Methyl 16.beta.-hydroxy-17-acetoxy-kauran-19-oate
| Title | Journal or Book | Year |
|---|---|---|
| The Pagodane Route to Dodecahedranes Unsaturated (Hyperstable) and Saturated Bissecododecahedranes | Chemische Berichte | 1992 |